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1. Introduction
Hepatic encephalopathy (HE) is a neuropsychiatric syndrome that develops in patients with
severe  liver  diseases  and/or  portal-systemic  shunting.  HE  is  characterized  by  a  wide
spectrum of clinical manifestations, ranging from alterations of psychometric performance
to stupor and coma (Rovira et al., 2008; Cordoba J., 2011). Several non-invasive neuroimag‐
ing  techniques,  such  as  particularly  magnetic  resonance  imaging  (MRI)  and  magnetic
resonance spectroscopy (MRS), are used for the diagnosis and prognosis of HE. These MR
techniques can identify and measure the abnormal accumulation and increase of metabo‐
lite, such as glutamine and glutamate (Glx) as a result of HE in the central nervous system
(CNS).  Under normal  circumstances,  these  substances  are  efficiently  metabolized by the
liver. This chapter will review the pathophysiology of HE and its conventional MRI, MRS
and functional MRI findings.
2. Pathophysiology of hepatic encephalopathy
Various  hypotheses  have  been  proposed  to  explain  the  complex  neuropsychiatric  syn‐
drome seen in  HE.  Imbalance  between inhibitory  and excitatory  neurotransmission and
hyperammonemia is the primary and most widely accepted hypothesis for HE (Rovira et
al., 2008; Butterth et al., 2003; Cordoba J., 2011; Cordoba & Minguczb., 2008). Downregula‐
tion of glutamate receptors and an increase in inhibitory neurotransmission result in clinical
manifestations  of  HE.  In  addition,  patients  with  liver  failure  or  portal-systemic  shunt
surgery have elevated levels of circulating ammonia, which enters the brain through the
blood-brain barrier, and increases the ammonia concentration in the cerebral blood up to
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four fold (normally in the order of two) in liver failure. Hyperammonemia disease leads to
profound astrocyte changes, including astrocyte swelling in acute HE and Alzheimer type
II astrocyte changes in chronic HE (Matsusue et al., 2005).
3. Clinical features of hepatic encephalopathy
The Working Party at the 11th  World Congresses of Gastroenterology, held in Vienna in
1998, recommended the nomenclature and types of HE (Table 1) (Ferenci et al., 2002). The
West Haven criteria for semi-quantitative grading of HE are summarized in Table 2. HE
can be classified in three main groups: episodic, chronic, and minimal, based on duration
and  characteristics  of  the  clinical  manifestations.  Episodic  HE  is  characterized  by  the
development of an impaired mental state, neuromuscular abnormalities, asterixis (tremor,
jerking movement of the wrist), fetor hepaticus (metcarpans pass into the lungs resulting
in  the  presence  of  ammonia  and  ketones  in  the  breath),  and  hyperventilation,  which
develops during a short period of time and fluctuates in severity. Chronic HE can be further
classified into subgroups: relapsing HE and persistent HE. Relapsing HE manifests itself as
frequent  episodes of  acute HE,  while  persistent  HE refers  to  manifestations that  do not
reverse despite adequate treatment. Characteristic manifestations of severe persistent HE
are dementia, Parkinsonism, or myelopathy in combination with neurologic involvement,
such as ataxia, gait abnormalities, tremor (Rovira et al., 2008). Minimal HE refers to those
patients  HE  type  with  cirrhosis  or  portal-systemic  shunts  who  have  subtly  abnormal
cognitive and/or neurophysiologic functions. These abnormalities cannot be detected by the
standard clinical examination and can only be determined by a detailed assessment of the
patient’s history and a comprehensive neurologic evaluation of cognitive performance and
motor functions. The neuropsychological features of the minimal HE type include abnormal‐
ities  in  executive  functions,  particularly  in  selective  attention  and  psychomotor  speed
(Amodio et al., 2004). However, other abnormalities, such as memory impairments, are also
seen (Amodio et al., 2004). A complete psychometric assessment by a neuropsychologist is
the best way to determine the extent of the attention-related cognitive impairment of a HE
patient.  A  large  number  of  neuropsychologic  tests,  such  as  the  number  connection  test
(NCT), the line-tracing, and inhibitory control test have been developed and are applied to
describe cognitive abnormalities in patients without any clinical evidence of HE (Ferenci et
al.,  2002;  Amodio  et  al.,  2010).  Testing  across  various  neuropsychological  domains  is
probably the optimal approach in order to identify cognitive and motor system abnormal‐
ities, such as attention and fine motion control. A standardized test battery, including the
NCT type A and NCT type B, the line-tracing, the serial-dotting, and the digit-symbol tests
(PSE-Syndrome-Test)  has  a  high  specificity  for  HE  as  compared  with  other  metabolic
encephalopathies (Ferenci et al., 2002). Changes in EEG/evoked responses and neuroimag‐
ing findings are non-specific and may not be able to provide sufficient information for the
diagnosis of minimal HE.
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HE 
type 
Nomenclature Subcategory Subdivisions 
A Encephalopathy associated with 
acute liver failure 
  
B Encephalopathy associated with 
portal-systemic bypass and no 
intrinsic hepatocellular disease 
  
C Encephalopathy associated with 
cirrhosis and portal cirrhosis and 
portal hypertension/ or portal-
systemic shunts 
Episodic HE Precipitated, 
spontaneous, recurrent 
  Persistent HE Mild, severe, treatment-
dependent 
  Minimal HE  
Table 1. The nomenclature of HE
Grade Criteria 
1 Trivial lack of awareness, euphoria or anxiety, shortened attention span, 
impaired performance of addition 
2 Lethargy or apathy, minimal disorientation for time or place, subtle 
personality change, inappropriate behaviour, impaired performance of 
subtraction 
3 Somnolence to semi stupor, but responsive to verbal stimuli; confusion; gross 
disorientation 
4 Coma (unresponsive to verbal or noxious stimuli) 
Table 2. West Haven criteria for semiquantitative grading of HE 
Table 2. West Haven criteria for semiquantitative grading of HE
4. Conventional MRI findings
In MRI exam of HE, bilateral hyperintensities at basal ganglia in T1 weighted images but
without the corresponding abnormal T2 weighted signal intensity is a typical imaging feature
of HE (Figure 1A).This imaging characteristic is attributed to hypermanganesemia (Gover et
al., 2006; Mcphail & Taylor-Robinson., 2010).
The observed hyperintensities in bilateral basal ganglia on T1 weighted images can be reduced,
or even disappear, after liver transplantation (Figure 1B and 1C) (Naegele et al., 2000; Cordoba
et al., 2001; Long et al., 2009). However, no correlation between signal intensities on T2
weighted images in basal ganglia and the clinical encephalopathy or neuropsychological test
performance was found, after a number of studies (Spahr et al., 2002; Thuluvath et al., 1995).
Although mild brain oedema has been reported in the studies using other advanced MR
sequences, no mild abnormalities can be detected in the conventional T1 and T2 weighted
images, in addition to basal ganglia hyperintensity. Some studies reported high signal intensity
at the centrum semiovale or corticospinal tract (along the hemispheric white matter in or
around the corticospinal tract) on fast fluid attenuated inversion recovery (FLAIR) T2-
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weighted images (Figure 2) (Mínguez et al., 2007; Rovira et al., 2008). This is strikingly similar
to signalintensity abnormalities noted in cases of amyotrophic lateral sclerosis, a neurodege‐
nerative disease that affects motor neurons. The progressive normalization of the abnormal
high signal-intensity in patients with cirrhosis can be found after the successful liver trans‐
plantation or effective treatment (Mínguez et al., 2007; Rovira et al., 2008). Therefore, obser‐
vation of FLAIR white matter hyperintensities without additional imaging sequences, such as
T2 weighted images cannot be used to diagnose HE.
A B C 
Figure 2. Coronal FLAIR images of a cirrhotic patient A to C. Coronal FLAIR images show the areas with abnormal high
signal intensity in or around the corticospinal tract (arrows).
  
               A                        B                        C 
Figure 1. T1 weighted spin echo images of a selected axial brain section from a patient before and after receiving liver
transplantation A) An axial T1 weighted image shows the symmetrical areas with high intensity in bilateral basal gan‐
glia (arrows) before liver transplantation; B) 1 week after liver transplantation; and C) 4 months after liver transplanta‐
tion, noticing that the symmetrical high intensity in bilateral basal ganglia shown in A, B, has disappeared.
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5. Magnetic transfer imaging (MTI)
Magnetic transfer imaging (MTI) is a singular MRI technique that has been shown to be useful
in the diagnosis of HE. It is mainly based on the interaction (cross-relaxation) between protons
in a relatively free environment and those in which motion is restricted (immobile water).
Exchange of the saturated magnetization with free water reduces the signal intensity observed
in the subsequent MR images. The degree of the signal-intensity loss depends on the attenu‐
ation of the macromolecules in a given tissue. MTI allows the measurement of magnetic
transfer ratios (MTR), which reflect brain parenchymal changes that may not be visible using
the standard MR techniques (Mcphail & Taylor-Robinson., 2010; Grover et al., 2006). Lower
MTR can be the result of pathologies that alter the structural integrity and the relative
macromolecular-water composition of brain parenchyma, such as in multiple sclerosis plaques
(Rovira et al., 1999) or in end-stage cirrhosis (Rovira et al., 2001). Severe MTR decrease may be
attributed to the demyelination and axonal loss, but a less severe decrease can be the result of
inflammation and moderate demyelination.
All studies using MTI in HE found reduced MTR values in the examined brain regions of HE
patients compared to those of controls (Miese et al., 2006; Miese et al., 2009; Poveda et al.,
2010). Observed MTR decrease is mild (approximately 10%) and is not accompanied by
significant abnormalities on conventional T1-and T2-weighted images, compared with the
other metabolic and neurodegenerative diseases, such as experimental autoimmune encepha‐
lomyelitis, toxic demyelination, progressive multifocal leukoencephalopathy, human immu‐
nodeficiency virus encephalitis, and multiple sclerosis. The MTR reduction seems to have a
temporal process in HE, an early involvement of basal ganglia and white matter has been
shown (Miese et al., 2009). The MTR decrease almost returns to normal values after liver
transplantation, thus supporting the hypothesis that the reduced MTR values reflect mild
reversible brain edema.
6. Diffusion weighted imaging and diffusion tensor imaging
Diffusion weighted imaging (DWI) is an MRI method that generates brain images based on
the image contrast that is dependent on the mobility of H2O molecules in the different tissue
compartments (Thoeny & De Keyzer, 2011). Water molecule motion follows the principles of
Brownian motion (Provenzale et al., 2006). In a container of water, molecules undergo free,
thermally agitated diffusion, which is also called isotropic (means equal in all directions).
However, limited diffusion is observed since the movement of water molecules is restricted
by their interactions with cell membranes and macromolecules, causing the directional specific
motion of water molecules in environments, which is called anisotropic diffusion (Figure 3).
DWI derives its image contrast on the basis of differences in the mobility of protons (primarily
associated with water) between tissues (Thoeny & De Keyzer., 2011). Apparent diffusion
coefficient (ADC) is a measurement obtained from DWI that provides estimation of water
motion. DWI has a potential to locate the compartment where the increase of mobility of water
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molecules is more prominent. Therefore, it can be applied to differentiate cytotoxic oedema
from vasogenic oedema in HE patients (Lodi et al., 2004; Mies et al., 2006; Sugimoto et al.,
2008). Brain oedema refers to excess water accumulation in the intracellular and extracellular
spaces of the brain. In cytotoxic oedema, there is shift of water from extracellular to intracellular
compartments producing cellular swelling expressing low ADC, while in vasogenic oedema
the reverse happens, producing increased ADC (Schaefer et al., 2000). Recent studies on the
application of mean diffusivity measurements within normal-appearing white matter of
chronic cirrhotic patients have shown significant increase in brain water diffusivity, which is
more pronounced with increased severity of HE (Lodi et al., 2004). These diffusivity values
correlated with neuropsychological impairment (Kumar et al., 2008) and increased venous
ammonia (Lodi et al., 2004). These findings suggest an accumulation of water in the extracel‐
lular compartment and a hypothesis of cortical astrocytic swelling is not supported, but rather
increased interstitial fluid or chronic demyelination (Lodi et al., 2004; Sugimoto et al., 2008;
Miese et al., 2006) due to glutamine accumulation is cited as the cause of diffuse brain oedema
in chronic liver failure (Lodi et al., 2004; Sugimoto et al., 2008; Miese et al., 2006).
On the other hand, the morphology and structure of tissues vary in different organs and
pathologic states. Water motion occurs preferentially in some directions in certain tissues due
to the presence of obstacles that limit molecular movement in some directions. Diffusion-tensor
imaging (DTI) can be used to obtain anisotropy information about water diffusion in tissues
when specific diffusion weighted gradients in at least six directions are applied. The most
commonly used invariant indices for the measurement of anisotropic diffusions by DTI are;
the relative anisotropy (RA), the fractional anisotropy (FA), and the volume ratio (VR) indices
(Figure 4A). In brain imaging applications, these indices provide a quantitative measurement
of the changes of white matter integrity in different brain regions that are affected by HE. Using
DTI together with advanced fibre-tracking algorithms based on the obtained diffusion tensors,
white matter tractography can be derived from DTI data. Therefore, it is possible to noninva‐
sively construct 3D trajectories of neural tracts, allowing the modelling of white matter neural
connectivity (Figure 4B) (Mukherjee et al., 2008a; Mukherjee et al., 2008).
Figure 3. Schematic illustrations describe the isotropic diffusion and anisotropic restricted diffusion
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FA, an index reflecting the white matter integrity, shows no significant changes in patients
with chronic HE compared with normal subjects, indicating an absence of microstructural
damage in these patients (Kale et al., 2006). Recently, a study by Chavarria et al. (Chavarria et
al., 2010) into a rat model of acute liver failure provided experimental evidence to support the
cytotoxic origin of brain oedema. Their results suggested that the metabolism of ammonia in
astrocytes induces an increase of glutamine and lactate, which may mediate cortical cellular
swelling. Saksena et al. (Saksena et al., 2007) also found decreased mean diffusivity values in
patients with acute liver failure, suggesting an increase in the intracellular brain water content.
Other studies also found decreased ADC value and high cortical signal intensity in patients
with acute HE (McKinney et al., 2010; Toru et al., 2011). Therefore, it appears that two different
types of brain oedema, intracellular in acute forms and probably interstitial in chronic forms,
may exist in liver failure.
7. Magnetic Resonance Spectroscopy (MRS)
MRS is a non-invasive analytical method for analysing brain metabolites, often accompanied
by MRI in neuroradiology practices. MR spectroscopic analysis offers a tool to interrogate the
molecular process within body tissue and fluids in vivo and in vitro. In clinical application,
MRS is capable of identifying and measuring the individual chemicals in the brain regions
localized and sampled from MR images. 1H MRS can provide information about brain
metabolites such as choline (Cho), creatine (Cr), N-acetyl aspartate (NAA), glutamine and
glutamate (Glx), as well as osmolytes, such as myoinositol (mI) and taurine (Ross et al., 1994;
Kreis R et al., 1992; Cordoba et al., 2002; Mcphail & Taylor-Robinson. 2010). NAA is a derivative
of an amino acid found mostly in neurons; therefore, it is commonly considered as a measure
of neuronal density. The peak at 3.19-3.24 ppm of MR spectra obtained in vivo represents a
total Cho, including soluble membrane phospholipids: phosphorylcholine (PCho), glycero‐
  
              A                                 B  
Figure 4. Presentations of diffusion tensor images of a cirrhotic patient acquired at a 3T MR scanner A. FA image, B.
tractography of the brain derived from diffusion tensor imaging
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phosphocholine (GPC) and a relatively small amount of free choline. PCho is involved in the
synthesis of the insoluble membrane phospholipids (Vance DE, 1996), while GPC is a product
of membrane degradation and free choline is involved in synthesis of the neurotransmitter,
acetylcholine, as well as of membrane synthesis (Michel et al., 2006). An increase in the total
Cho peak is associated with an increase in membrane breakdown or turnover, myelination or
inflammation (Astley et al., 2009). The peak of Cr spectrum is assigned at 3.02 ppm. This peak
represents a combination of molecules containing creatine and phosphocreatine. When energy
supply is insufficient from the Kreb’s cycle, ATP is produced from adenosine diphosphate
(ADP) instead of glucose. This reaction is buffered by the phosphocreatine–creatine (PCr-Cr)
system, where PCr donates a phosphate group to become Cr. It is assumed that the Cr peak
reflects energy use. Glutamine and glutamate (Glx) are amino acids. Glutamate is the most
abundant amino acid in the brain and is released by approximately 90% of excitatory neurons.
The spectral peaks of these molecules are often grouped together as Glx in the spectra obtained
at the low field, because their overlap makes it hard to resolve them separately. Two com‐
pounds become increasingly separated in the higher magnetic fields; therefore, with the
increasing clinical availability of stronger magnets, there is growing importance and interests
in studying these compounds. Myo-inositol (mI), a simple sugar-alcohol compound, and
precursor for inositol lipid synthesis, is a putative glial cell marker because it is located
primarily in glial cells and not in neurons. Astrocytes, microglia, and macrophages have been
shown to increase their levels of the Na+/mI cotransporter (SMIT) in response to stress or injury
and an accumulation of mI, suggesting a role of this compound in inflammation and a marker
for astrogliosis and microglia activity (Gupta et al., 2010).
1H MRS has been extensively used in HE studies and has consensus findings on the intracel‐
lular metabolite changes in HE. Typical 1H MRS findings of HE include: lower Cho/Cr and
mI/Cr and higher Glx/Cr in all examined brain regions compared with controls (Figure 5)
(Taraow et al., 2003; Weissenborn et al., 2004; Stewart et al., 2005; Mechtcheriakov et al., 2005;
Miese et al., 2006; Weissenborn et al.,2007; Verma et al., 2008). Ammonia plays an important
role in the series of metabolite changes in patients with cirrhosis. The increase in brain
glutamine during HE increases intracellular osmolality. To maintain osmotic equilibrium, the
astrocytes lose osmolytes such as mI and Cho, and a large amount of water enters the astrocyte
and results in cellular swelling and impairment of cellular metabolism, further influencing
neuronal and astrocyte function and the interaction between them. MRS measurable metabo‐
lite changes have been shown to correlate with improved psychometric performance (Binesh
et al., 2006) following treatment (Haseler et al., 1998) and following liver transplantation
(Naegele et al., 2000; Córdoba et al., 2001; Long et al., 2009). Recent pilot studies on in vitro 1H
MRS of human blood or urine in acute liver failure have demonstrated significant metabolite
abnormalities between survivors and nonsurvivors (Saxena et al., 2006). They found glutamine
in serum and the urine glutamine: creatinine ratio was higher in non-surviving patients
compared with surviving patients [serum glutamine, 3.08 (1.68-7.11) vs. 0.56 (0.34-0.99) mM,
median and range; P=0.0001 and urine glutamine:creatinine ratio, 1.72 (0.24-7.76) vs. 0.39
(0.1-0.84), P=0.1], and urine urea:creatinine ratio was higher in surviving patients compared
with non-surviving patients [10.83 (0.2-22.6) vs. 2.09 (0.96-4.0), P=0.002]. Their study indicated
MRS had a potential use for clinical decision making about the need for advanced therapeutic
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intervention, such as artificial liver support or emergency liver transplantation in acute liver
failure. Of these available MRS measurements, mI seems to be a more sensitive biomarker than
Cho to detect HE. mI levels were negatively related to the Child-Pugh score and degree of HE
(Lee et al., 1999; Zhang et al., 2010). However, values in a normal range have not been
established and the diagnostic accuracy of 1H-MRS remains uncertain.
   A.                    B. 
   C.                    D. 
 
 
 
 
 
 
 
      E                    F 
 
 
 
      G                    H 
Figure 5. A set of brain MR spectra of HE patients and normal control A) A MRS spectrum obtained from the anterior
cingulate cortex (ACC) of a healthy adult. B) A MRS spectrum of the anterior cingulate cortex from a 25-year-old fe‐
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male cirrhotic patient. C) MRS of the anterior cingulate cortex of a 44-year-old minimal hepatic encephalopathy (MHE)
patient shows decreased mI and increased Glx. D) MRS of anterior cingulate cortex of a 70-year-old HE patient shows
decreased mI and Cho and increased Glx. E) MRS of right basal ganglia of the same subject as in A). F) MRS of right
basal ganglia in the same patient as in B) shows decreased mI and Cho. G) MRS of right basal ganglia of the same
patient as in (C) shows decreased mI and Cho and increased Glx. H) MRS of right basal ganglia of the same patient in
(D) shows decreased mI and Cho and increased Glx. The spectra were collected using single voxel PRESS sequence at
1.5T scanner.
In clinical practice, accurately differentiating some metabolites, such as Glx and taurine, can
be challenging with the clinical MR scanners currently available. Two-dimensional MR
spectroscopy may enhance the spectral resolution to distinguish metabolites based on J
coupling patterns of individual molecules. On the other hand, more sophisticated statistical
techniques, such as principal components analysis (PCA), enable assessment of the variation
in individual metabolites based on the data obtained from MRS measurements (Barba et al.,
2008; Singhal et al., 2010). These techniques can provide quantitative information of metabolic
processes and changes in the diseased tissue, and therefore can be helpful in the understanding
of HE pathogenesis. Wide availability of 3 Tesla MR scanners, as well as short TE acquisition,
can improve the spectral resolution and thus, allow the differentiation of Glx from NAA
(Sawara et al., 2004).
8. Blood oxygen level dependent functional MRI
Functional magnetic resonance imaging (fMRI) detects blood oxygen level-dependent (BOLD)
changes in MRI signal that arise when changes in neuronal activity occur in a region of the
brain after responding to a stimulus or performing a specific task (Ogawa et al., 1992). The
BOLD signal is the ratio of oxy-haemoglobin to deoxy-haemoglobin during brain activation
(Gore JC., 2003).
According to experimental paradigms, fMRI can be classified to task-related and resting state
fMRI. In task-related fMRI design, a subject is placed in the magnet of an MRI machine, where
various different kinds of stimulus are administered in a controlled fashion. Two main
experimental paradigms are commonly used in task-related fMRI studies: block design and
event-related paradigms (Gore JC., 2003). In resting state fMRI, the participants are required
to rest in the absence of any external stimulation as well as guided to avoid reiterating any
goal-directed thought pattern in their heads (Damoiseaux et al., 2006).
Many behavioural studies have claimed the existence of attention alterations in cirrhotic
patients without overt HE (Zhang et  al.,  2007a;  Randolph et  al.,  2009;  Bajaj  et  al.,  2009).
There  are  only a  few fMRI studies  into  HE.  Zafiris  et  al.  (Zafiris  et  al.,  2004)  first  ana‐
lysed the pathologically impaired neural mechanisms of cirrhotic patients using fMRI. Nine
subjects with minimal HE (MHE) and 10 controls underwent scanning while they indicat‐
ed the apparent  transition from a steady light  to the onset  of  a  flicker  light.  Judgment-
related BOLD activation was decreased in MHE patients compared to controls in the right
inferior parietal cortex (IPL). Impaired neural interaction between the IPL and the parietooc‐
cipital cortex (Poc), the intraparietal sulcus, the anterior cingulate cortex (ACC), the right
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prefrontal cortex (PFC),  the medial temporal lobe,  and the extrastriate cortex V5 and an
enhanced coupling between IPL and the postcentral cortex were found in MHE patients.
This study demonstrated an impaired and compensatory neural mechanism during visual
judgment in the earliest stages of HE. Zhang et al.  (Zhang et al.,  2007a) used a Chinese
character  Stroop task as  the  target  stimulus  to  investigate  the  neural  mechanism of  the
cognitive  control  impairment  in  cirrhotic  patients  using  fMRI.  This  study  showed  that
simple tasks (incongruous word-reading tasks) increased the activity of the precentral and
postcentral gyri in cirrhotic patients, and harder tasks (incongruous colour-naming tasks)
decrease the activity of bilateral superior frontal gyrus, middle frontal gyrus, inferior frontal
gyrus,  medial  wall  frontal  gyrus,  ACC, temporal  cortex,  and parietal  cortex.  This  study
provides  suggests  that  the  abnormal  anterior  cingulate  cortex–prefrontal  cortex–parietal
‘‘fusiform’’  cortex  circuit  could  be  the  neural  substrarte  responsible  for  this  impaired
A B 
C D 
＜
＜
：
Figure 6. Default mode network changes of HE patients A) DMN of the controls consists of bilateral precuneus/poste‐
rior cingulate cortex, medial prefrontal cortex, anterior cingulate cortex, angular gyri, and temporal pole (P < 0.05, FDR
corrected). B) DMN of HE patients consists of bilateral precuneus/posterior cingulate cortex, medial prefrontal cortex,
anterior cingulate cortex, angular gyri, and temporal pole (P < 0.05, FDR corrected). Patterns in the HE patients are
similar but with a reduced size compared to the ones of normal subjects in (A). C) Differences between the DMN of
the HE patients and the controls are noted in the left posterior cingulate cortex and bilateral precuneus, right angular
gyrus, bilateral middle frontal cortex, and left parahippocampus (P<0.05 for all, uncorrected) and in the right middle
frontal gyrus and left posterior cingulate cortex (P<0.05 corrected, combined height threshold P < 0.01 and a mini‐
mum cluster size of 24 voxels). D) Statistical t-maps of the venous blood ammonia against z-scores in ICA in the HE
group. The right middle frontal gyrus, left posterior cingulate cortex, left parahippocampus, bilateral angular gyri
(P<0.05 for all, uncorrected) and the left angular gyrus colour-coded bright blue (P<0.05 corrected, combined height
threshold P<0.01 and a minimum cluster size of 24 voxels) had a negative correlation with venous blood ammonia.
From Zhang et al., Brain default-mode network abnormalities in hepatic encephalopathy: a resting-state functional
MRI study. Hum Brain Mapp, 2011, DOI:10.1002/hbm.21295, with permission
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cognitive control. However, the task-induced fMRI is better suited to the patients with low-
grade or MHE who can perform the test tasks (Mcphail and Taylor-Robinson, 2010).
Recently, increasing attention has been given to detecting brain activities during resting state
(Greicius et al., 2003; Greicius et al., 2004; Zhang et al., 2007b; Zhang et al., 2011). Most reported
resting-state network components include; the default mode network (DMN), the sensorimo‐
tor component, the executive control component, up to three visual components, two lateral‐
ized fronto-parietal components, the auditory component and the temporoparietal component
(Rosazza & Minati, 2011). As already reported, these resting-state networks consist of ana‐
tomically distinct, but functionally connected regions, which display a high level of correlated
BOLD signal activity. Nowadays the DMN is the most studied network in comparison to task-
induced brain networks. DMN includes the medial prefrontal cortex, rostral anterior cingulate,
posterior cingulated cortex (PCC), and precuneus (Greicius et al., 2003; Greicius et al., 2004).
The DMN is described by increased activity during rest, while decreased activation suppressed
during cognitively demanding tasks, such as visual and auditory attention, language proc‐
essing, memory, and motor activities. Abnormal default function network has been known to
relate to Alzheimer disease (AD), autism, attention deficit hyperactivity disorder, schizophre‐
nia, epilepsy, and other diseases (et al., 2005; Rombouts et al., 2005; Kennedy et al., 2006; Liang
M, et al., 2006; Tian et al., 2006).
In a study by Zhang et al. (Zhang et al., 2007), the DMN of the cirrhotic patients was investi‐
gated using a block-design in which a modified Chinese Stroop task was used as the target
stimulus. In this study, a subtraction method was used to study the resting-state network in
patients with hepatic cirrhosis. The functional data suggest that cirrhotic patients may have a
deactivated DMN. The absence of deactivation in the PCC and precuneus may be a sensitive,
rather than specific, marker in patients with hepatic cirrhosis. Recently, in a resting state fMRI
study (Zhang et al., 2011), a significantly reduced functional connectivity in the right middle
frontal gyrus, left precuneus, and left PCC in the HE patients was observed when compared
to the controls. A negative correlation was shown between left angular gyrus and left PCC
activation and venous blood ammonia levels, suggesting this can be an important biomarker
for HE (Figure 6).
9. Conclusion
In conclusion, HE appears as diffuse mild brain oedema, and is associated with cognition
functional changes such as attention, and functional brain area changes, such as default mode
brain areas. HE-associated functional and physiological abnormalities have been demonstrat‐
ed by a variety of MR techniques. MRI offers a range of capabilities for investigating HE in
clinical diagnosis. The recent development of fMRI and MRS expands the applications of the
study of HE with the capability of assessing functional changes in brain affected by HE. These
advances opens up the opportunities to better understand the pathopsychological mechanisms
of HE.
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